Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Fig. 2: Violin plots illustrating significantly different first-trimester serum biomarkers between the GDM group and the normoglycemia control group. | Nutrition & Diabetes

Fig. 2: Violin plots illustrating significantly different first-trimester serum biomarkers between the GDM group and the normoglycemia control group.

From: Novel first-trimester serum biomarkers for early prediction of gestational diabetes mellitus

Fig. 2

A Violin plots of ten first-trimester serum cytokines, including IL-1α, IL-1β, IL-3, IL-5, IL-7, IL-10, IL-12 (p40), IL-15, IL-18, and TNF-α, in the GDM group (n = 38) and normoglycemia control group (n = 38). B Serum levels of five first-trimester serum antibodies (total IgM, total IgG, aPS IgA, and aPS-IgG IC) in the GDM group (n = 38) and normoglycemia control group (n = 38). Data are presented as the mean ± standard deviation or median (interquartile range). *P < 0.05; **P < 0.01; ***P < 0.001. aPS anti‑phosphatidylserine, GDM gestational diabetes mellitus, IC immune complex, Ig immunoglobulin, IL-1α interleukin-1α, IL-1β interleukin-1β, IL-3 interleukin-3, IL-5 interleukin-5, IL-7 interleukin-7, IL-10 interleukin-10, IL-12 (p40) interleukin-12 (p40), IL-15 interleukin-15, IL-18 interleukin-18, TNF-α tumor necrosis factor‑α.

Back to article page

Search

Quick links

Morty Proxy This is a proxified and sanitized view of the page, visit original site.